In vitro and in vivo blood-brain barrier penetration studies with the novel cyanide antidote candidate dimethyl trisulfide in mice

Lóránd Kiss, Alexandra Bocsik, Fruzsina R. Walter, James Ross, Denise Brown, Brooke A. Mendenhall, Sarah R. Crews, Jana Lowry, Valerie Coronado, David E. Thompson, Peter Sipos, P. Szabó-Révész, Mária A. Deli, Ilona Petrikovics

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Recent in vitro and in vivo studies highlight the strong potential of dimethyl trisulfide (DMTS) as an antidote for cyanide (CN) intoxication. Due to its high oxygen demand, the brain is one of the main target organs of CN. The blood-brain barrier (BBB) regulates the uptake of molecules into the brain. In the literature, there is no data about the ability of DMTS to penetrate the BBB. Therefore, our aim was to test the in vitro BBB penetration of DMTS and its in vivo pharmacokinetics in blood and brain. The in vitro BBB penetration of DMTS was measured by using a parallel artificial membrane permeability assay (BBBPAMPA), and a triple BBB co-culture model. The pharmacokinetics was investigated in a mouse model by following the DMTS concentration in blood and brain at regular time intervals following intramuscular administration. DMTS showed high penetrability in both in vitro systems (apparent permeability coefficients: BBB-PAMPA 11.8 × 10-6 cm/s; cell culture 158 × 10-6 cm/s) without causing cell toxicity and leaving the cellular barrier intact. DMTS immediately absorbed into the blood after the intramuscular injection (5 min), and rapidly penetrated the brain of mice (10 min). In addition to the observed passive diffusion in the in vitro studies, the contribution of facilitated and/or active transport to the measured high permeability of DMTS in the pharmacokinetic studies can be hypothesized. Earlier investigations demonstrating the antidotal efficacy of DMTS against CN together with the present results highlight the promise of DMTS as a brain-protective CN antidote.

Original languageEnglish
Pages (from-to)398-407
Number of pages10
JournalToxicological Sciences
Volume160
Issue number2
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Antidotes
Cyanides
Blood-Brain Barrier
Brain
Pharmacokinetics
Permeability
Blood
dimethyl trisulfide
In Vitro Techniques
Artificial Membranes
Active Biological Transport
Intramuscular Injections
Hydraulic conductivity
Coculture Techniques
Cell culture
Toxicity
Assays
Cell Culture Techniques
Oxygen
Membranes

Keywords

  • Blood brain barrier penetration
  • Cyanide antagonism
  • Dimethyl trisulfide
  • In vitro
  • In vivo
  • Sulfur donors

ASJC Scopus subject areas

  • Toxicology

Cite this

Kiss, L., Bocsik, A., Walter, F. R., Ross, J., Brown, D., Mendenhall, B. A., ... Petrikovics, I. (2017). In vitro and in vivo blood-brain barrier penetration studies with the novel cyanide antidote candidate dimethyl trisulfide in mice. Toxicological Sciences, 160(2), 398-407. https://doi.org/10.1093/toxsci/kfx190

In vitro and in vivo blood-brain barrier penetration studies with the novel cyanide antidote candidate dimethyl trisulfide in mice. / Kiss, Lóránd; Bocsik, Alexandra; Walter, Fruzsina R.; Ross, James; Brown, Denise; Mendenhall, Brooke A.; Crews, Sarah R.; Lowry, Jana; Coronado, Valerie; Thompson, David E.; Sipos, Peter; Szabó-Révész, P.; Deli, Mária A.; Petrikovics, Ilona.

In: Toxicological Sciences, Vol. 160, No. 2, 01.12.2017, p. 398-407.

Research output: Contribution to journalArticle

Kiss, L, Bocsik, A, Walter, FR, Ross, J, Brown, D, Mendenhall, BA, Crews, SR, Lowry, J, Coronado, V, Thompson, DE, Sipos, P, Szabó-Révész, P, Deli, MA & Petrikovics, I 2017, 'In vitro and in vivo blood-brain barrier penetration studies with the novel cyanide antidote candidate dimethyl trisulfide in mice', Toxicological Sciences, vol. 160, no. 2, pp. 398-407. https://doi.org/10.1093/toxsci/kfx190
Kiss, Lóránd ; Bocsik, Alexandra ; Walter, Fruzsina R. ; Ross, James ; Brown, Denise ; Mendenhall, Brooke A. ; Crews, Sarah R. ; Lowry, Jana ; Coronado, Valerie ; Thompson, David E. ; Sipos, Peter ; Szabó-Révész, P. ; Deli, Mária A. ; Petrikovics, Ilona. / In vitro and in vivo blood-brain barrier penetration studies with the novel cyanide antidote candidate dimethyl trisulfide in mice. In: Toxicological Sciences. 2017 ; Vol. 160, No. 2. pp. 398-407.
@article{12bbd858e87847cdb60c5b3490d9703a,
title = "In vitro and in vivo blood-brain barrier penetration studies with the novel cyanide antidote candidate dimethyl trisulfide in mice",
abstract = "Recent in vitro and in vivo studies highlight the strong potential of dimethyl trisulfide (DMTS) as an antidote for cyanide (CN) intoxication. Due to its high oxygen demand, the brain is one of the main target organs of CN. The blood-brain barrier (BBB) regulates the uptake of molecules into the brain. In the literature, there is no data about the ability of DMTS to penetrate the BBB. Therefore, our aim was to test the in vitro BBB penetration of DMTS and its in vivo pharmacokinetics in blood and brain. The in vitro BBB penetration of DMTS was measured by using a parallel artificial membrane permeability assay (BBBPAMPA), and a triple BBB co-culture model. The pharmacokinetics was investigated in a mouse model by following the DMTS concentration in blood and brain at regular time intervals following intramuscular administration. DMTS showed high penetrability in both in vitro systems (apparent permeability coefficients: BBB-PAMPA 11.8 × 10-6 cm/s; cell culture 158 × 10-6 cm/s) without causing cell toxicity and leaving the cellular barrier intact. DMTS immediately absorbed into the blood after the intramuscular injection (5 min), and rapidly penetrated the brain of mice (10 min). In addition to the observed passive diffusion in the in vitro studies, the contribution of facilitated and/or active transport to the measured high permeability of DMTS in the pharmacokinetic studies can be hypothesized. Earlier investigations demonstrating the antidotal efficacy of DMTS against CN together with the present results highlight the promise of DMTS as a brain-protective CN antidote.",
keywords = "Blood brain barrier penetration, Cyanide antagonism, Dimethyl trisulfide, In vitro, In vivo, Sulfur donors",
author = "L{\'o}r{\'a}nd Kiss and Alexandra Bocsik and Walter, {Fruzsina R.} and James Ross and Denise Brown and Mendenhall, {Brooke A.} and Crews, {Sarah R.} and Jana Lowry and Valerie Coronado and Thompson, {David E.} and Peter Sipos and P. Szab{\'o}-R{\'e}v{\'e}sz and Deli, {M{\'a}ria A.} and Ilona Petrikovics",
year = "2017",
month = "12",
day = "1",
doi = "10.1093/toxsci/kfx190",
language = "English",
volume = "160",
pages = "398--407",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - In vitro and in vivo blood-brain barrier penetration studies with the novel cyanide antidote candidate dimethyl trisulfide in mice

AU - Kiss, Lóránd

AU - Bocsik, Alexandra

AU - Walter, Fruzsina R.

AU - Ross, James

AU - Brown, Denise

AU - Mendenhall, Brooke A.

AU - Crews, Sarah R.

AU - Lowry, Jana

AU - Coronado, Valerie

AU - Thompson, David E.

AU - Sipos, Peter

AU - Szabó-Révész, P.

AU - Deli, Mária A.

AU - Petrikovics, Ilona

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Recent in vitro and in vivo studies highlight the strong potential of dimethyl trisulfide (DMTS) as an antidote for cyanide (CN) intoxication. Due to its high oxygen demand, the brain is one of the main target organs of CN. The blood-brain barrier (BBB) regulates the uptake of molecules into the brain. In the literature, there is no data about the ability of DMTS to penetrate the BBB. Therefore, our aim was to test the in vitro BBB penetration of DMTS and its in vivo pharmacokinetics in blood and brain. The in vitro BBB penetration of DMTS was measured by using a parallel artificial membrane permeability assay (BBBPAMPA), and a triple BBB co-culture model. The pharmacokinetics was investigated in a mouse model by following the DMTS concentration in blood and brain at regular time intervals following intramuscular administration. DMTS showed high penetrability in both in vitro systems (apparent permeability coefficients: BBB-PAMPA 11.8 × 10-6 cm/s; cell culture 158 × 10-6 cm/s) without causing cell toxicity and leaving the cellular barrier intact. DMTS immediately absorbed into the blood after the intramuscular injection (5 min), and rapidly penetrated the brain of mice (10 min). In addition to the observed passive diffusion in the in vitro studies, the contribution of facilitated and/or active transport to the measured high permeability of DMTS in the pharmacokinetic studies can be hypothesized. Earlier investigations demonstrating the antidotal efficacy of DMTS against CN together with the present results highlight the promise of DMTS as a brain-protective CN antidote.

AB - Recent in vitro and in vivo studies highlight the strong potential of dimethyl trisulfide (DMTS) as an antidote for cyanide (CN) intoxication. Due to its high oxygen demand, the brain is one of the main target organs of CN. The blood-brain barrier (BBB) regulates the uptake of molecules into the brain. In the literature, there is no data about the ability of DMTS to penetrate the BBB. Therefore, our aim was to test the in vitro BBB penetration of DMTS and its in vivo pharmacokinetics in blood and brain. The in vitro BBB penetration of DMTS was measured by using a parallel artificial membrane permeability assay (BBBPAMPA), and a triple BBB co-culture model. The pharmacokinetics was investigated in a mouse model by following the DMTS concentration in blood and brain at regular time intervals following intramuscular administration. DMTS showed high penetrability in both in vitro systems (apparent permeability coefficients: BBB-PAMPA 11.8 × 10-6 cm/s; cell culture 158 × 10-6 cm/s) without causing cell toxicity and leaving the cellular barrier intact. DMTS immediately absorbed into the blood after the intramuscular injection (5 min), and rapidly penetrated the brain of mice (10 min). In addition to the observed passive diffusion in the in vitro studies, the contribution of facilitated and/or active transport to the measured high permeability of DMTS in the pharmacokinetic studies can be hypothesized. Earlier investigations demonstrating the antidotal efficacy of DMTS against CN together with the present results highlight the promise of DMTS as a brain-protective CN antidote.

KW - Blood brain barrier penetration

KW - Cyanide antagonism

KW - Dimethyl trisulfide

KW - In vitro

KW - In vivo

KW - Sulfur donors

UR - http://www.scopus.com/inward/record.url?scp=85042559313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042559313&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfx190

DO - 10.1093/toxsci/kfx190

M3 - Article

VL - 160

SP - 398

EP - 407

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 2

ER -